Clinical Trial Update: Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing levalbuterol, racemic albuterol and placebo in subjects age 12 and older with asthma has completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Levalbuterol (Levalbuterol)
• Racemic albuterol (albuterol (racemic))

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED